FDA

White House Offers Guidance on Nanotechnology Policy

White House Offers Guidance on Nanotechnology Policy

EPA, FDA respond with calls for public comments.

Senate Hearing on Diabetes Urges Development of Artificial Pancreas

Senate Hearing on Diabetes Urges Development of Artificial Pancreas

Committee members urge FDA to expedite releasing industry guidance.

FDA Releases Action Plan on Imported Goods

FDA Releases Action Plan on Imported Goods

The plan would improve collaboration, data management, and resource allocation.

Week in Review

Week in Review

Regulatory news in review

FDA Approves New Hepatitis C Drugs

FDA Approves New Hepatitis C Drugs

Drug approval could signal new era in Hepatitis C treatment.

Week in Review

Week in Review

Regulatory news in review.

Week in Review

Week in Review

Regulatory news in review

FTC Issues Pay-for-Delay Report

FTC Issues Pay-for-Delay Report

Report finds consumer harm in rise of pay-for-delay agreements.

Week in Review

Week in Review

Regulatory news in review

Federal Research Center’s New Venture Into Drug Discovery

Federal Research Center’s New Venture Into Drug Discovery

New National Center for Advancing Translational Sciences works with pharmaceutical companies to develop drugs.

Week in Review

Week in Review

Regulatory news in review

Week in Review

Week in Review

Regulatory news in review